Testosterone Therapy and Your Heart: What the TRAVERSE Trial Found

A large 2023 trial tested whether testosterone therapy raises heart attack and stroke risk in men with low testosterone. Here's what it found, and what it didn't.

Key takeaways

  • TRAVERSE studied 5,246 men aged 45 to 80 with low testosterone and existing or high heart risk.
  • Major heart events occurred in 7.0% on testosterone vs. 7.3% on placebo, so testosterone was not worse.
  • Atrial fibrillation, acute kidney injury and blood clots in the lungs were more common with testosterone.
  • Accurate diagnosis and regular monitoring still come first.

For years, men with low testosterone heard mixed messages about their hearts. Some earlier studies raised the possibility that testosterone therapy might lead to more heart attacks or strokes. Others found no such link. Because the evidence was unclear, the American Urological Association's testosterone guideline asks doctors to tell patients that it can't be stated definitively whether testosterone therapy raises or lowers the risk of cardiovascular events 1.

In 2023, a large trial designed to answer this question was published in the New England Journal of Medicine. It's called TRAVERSE 2. Here's what it showed, in plain terms, and where its limits are.

Who was in the trial

TRAVERSE enrolled 5,246 men aged 45 to 80. Every man had symptoms of low testosterone and two fasting blood tests below 300 ng/dL. Each also either already had heart disease or was at high risk of it 2. That matters: this was the group doctors were most worried about.

The men were randomly assigned to use either a daily testosterone gel or a placebo gel. Neither the men nor their doctors knew who got which. Testosterone doses were adjusted to keep levels within a set range. On average, men were followed for about 33 months 2.

What it found

The main question was whether testosterone led to more heart attacks, strokes or deaths from cardiovascular causes. It did not. These events happened in 7.0% of men on testosterone and 7.3% of men on placebo. The researchers concluded that testosterone was "noninferior" to placebo, meaning not worse, for these major heart events 2.

The trial did find some differences worth knowing about. Men in the testosterone group had higher rates of:

  • Atrial fibrillation, an irregular heart rhythm
  • Acute kidney injury
  • Pulmonary embolism, a blood clot in the lungs

These outcomes were less common than the main heart events, but they are real. They belong in any conversation about starting treatment 2.

In early 2025, the U.S. Food and Drug Administration told makers of testosterone products to add the TRAVERSE results to their labels and to remove boxed-warning language about an increased risk of adverse cardiovascular outcomes. At that time the FDA kept the labels' limitation of use for low testosterone due to aging alone and added blood pressure warnings to testosterone products 3. In June 2026, HHS and the FDA asked for further label changes, including removing that age-related limitation of use 4. Labels are changing, so ask about the current prescribing information for any product you're offered.

What TRAVERSE doesn't tell us

Reassuring results on heart safety are not the same as proof that testosterone is right for everyone. A few limits are worth keeping in mind:

  • It studied men with confirmed low testosterone. The results don't apply to men with normal levels who take testosterone hoping for more energy or muscle.
  • It used a prescription gel at monitored doses. It says nothing about high-dose or non-prescribed use, such as anabolic steroids.
  • It didn't show a heart benefit. Testosterone was not worse than placebo. That's different from saying it protects the heart.
  • Many men didn't stay on treatment. The average time on treatment was about 22 months, well short of the average follow-up 2.

What this means if you're considering testosterone

The first step is still an accurate diagnosis. The AUA uses a total testosterone level below 300 ng/dL as a reasonable cut-off, confirmed with two early-morning tests on separate occasions, along with symptoms 1. One low result from an afternoon blood draw isn't enough.

If testosterone therapy makes sense for you, safe care includes:

  • Checking hemoglobin and hematocrit before treatment and during it, because testosterone can raise red blood cell levels 1
  • Adjusting the dose to aim for the middle of the normal range, not as high as possible 1
  • Reviewing blood pressure, heart rhythm symptoms and clot risk at follow-up visits
  • Talking about family plans first, because testosterone therapy should not be prescribed to men who are trying to conceive 1
The question is no longer only "Is testosterone bad for my heart?" It's "Do I truly have low testosterone, and do the expected benefits outweigh the specific risks for me?"

If you already take testosterone, don't stop it or change your dose on your own. Bring your questions and your most recent lab results to your next visit, and decide together with your doctor.

When to see a doctor

Talk with a doctor if you have symptoms of low testosterone, or if you take testosterone and have questions. Call 911 for chest pain, sudden shortness of breath, a racing irregular heartbeat with fainting, or signs of a stroke.

Sources and references

  1. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. Validity reviewed and confirmed by the AUA in 2024. View source
  2. Lincoff AM, Bhasin S, Flevaris P, et al.; TRAVERSE Study Investigators. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. View source
  3. U.S. Food and Drug Administration. FDA issues class-wide labeling changes for testosterone products. February 2025. View source
  4. U.S. Department of Health and Human Services. FDA requests updates to testosterone therapy labeling. June 2026. View source

About the author

Dr. Jason Greenfield, MD

Dr. Jason Greenfield, MD, is a board-certified urologist at Colorado Urology in Lone Tree, Colorado. His primary areas of expertise include the medical and surgical treatment of erectile dysfunction and Peyronie's disease.

This article is general education for adults and is not a substitute for personal medical advice. In an emergency, call 911.

Related articles

Ready to talk about your health?

Start with a private consultation at Colorado Urology in Lone Tree. Partners are welcome.

Request an Appointment